$293.72+21% 1Y

Is the price fair?

Watch

A demanding price: at the top of its own P/E range and rich vs its sector.

2 to watch, 1 neutral
What the price assumes~+13% a year

Priced for ~13% a year FCF growth. Roughly in line with its three-year revenue growth of 16% a year.

Vs its own P/E rangedearest in 35 quartersderived

Expensive vs its own history: P/E 30.3 vs a 18.5 median over 35 quarters (+63% vs median).

Vs sector (EV/EBIT)25.4×

Sector median 15.0× across 156 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Unless marked, from derived, as of Jun 27, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)behind 69% of the market
FCF yieldbehind 77% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What GRMN's price assumes

Garmin trades at 30.3× earnings against 35.5× for the median Scientific & Technical Instruments name, cheaper than its own group.

30.3

Trailing P/E · Scientific & Technical Instruments median 35.5 · cheaper than the typical name in its group

Price / sales
7.38

Price / sales · today's price, trailing year to Jun 27, 2026

Free cash flow yield
2.8%

Free cash flow yield · Scientific & Technical Instruments median 3.9%

Growth the price implies
+13%

Growth the price implies · The price pays for +13% free cash flow growth a year for a decade; the business has delivered +23% a year over the last three.

Details›
Price / booktoday's price, trailing year to Jun 27, 2026
6.27
EV / EBITtoday's price, trailing year to Jun 27, 2026
25.4
EV / salestoday's price, trailing year to Jun 27, 2026
7.03
Consumer Cyclical median P/E317 names
18.0
Scientific & Technical Instruments median P/E17 names
35.5
Free cash flow, trailing twelve months
$1.60B
Market capitalisation192.9 million shares, counted Jul 24, 2026
$56.6B
3-year revenue growth
+16%
3-year free cash flow growth
+23%
What the market has paid for these earnings: 35 quarters of its own multiple × $9.69 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$149.71
Its own P/E history, median$179.71
Its own P/E history, upper quartile$211.25
52-week range$184.77 – $313.03
Today$293.72

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

What is it worth?

Today's price against what its own multiples, its cash flow and your growth assumption say it is worth.

Against its own past

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.

On our screens:R&D leaders